Immunomedics (IMMU) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -7.66 | -10.2 | -5.25 | -6.66 | 1.58 | 2.69 | ||
| Changes by years, y/y, % | -306% | +33% | -49% | +27% | -124% | -15.8% | |||
Immunomedics. EV/EBITDA
Immunomedics. EV/EBITDA, changes, %
Immunomedics (IMMU) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2017Q4 | FY2018Q1 | FY2018Q2 | FY2020Q1 | FY2020Q2 | LTM ? | |||
| EV/EBITDA | ? | 0.18 | 0.54 | 1.58 | -12.3 | -27.9 | 2.69 | |
| Changes by years, y/y, % | -113% | -108% | -123% | |||||
| Changes by quarters, q/q, % | +93% | +198% | +192% | -879% | +127% | |||